Loading
Latest filing published 26 Jan 2024 for Volitionrx Ltd.
Based on 6 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Martin Charles Faulkes in Volitionrx Ltd. The record holds 30 filings, for trades running from 3 September 2014 to 24 January 2024.
The open-market side counts 8 purchases for €745k alongside 1 sale for €177k. The net balance comes to €569k on the buying side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 16 share grants and 4 option exercises.
The median purchase comes to €71k. 2 out of 5 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. Ninety days after publication, 6 purchases show a median change of +14.9%, with the price up in 50% of them. They describe history only and say nothing certain about the share price ahead.
The record was last updated on 26 January 2024 with a share grant in Volitionrx Ltd. The latest purchase dates back some time: it was published 1,149 days ago, on 1 September 2023. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 30 declarations